<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Kristina Meyer

Senior Analyst Sports Medicine: 12+ years' experience in marketing, field marketing and professional education, with a concentration on Sports Medicine. Marketing and Sales Management roles at Smith & Nephew and Stryker Sports Medicine.
Find me on:

Recent Posts

SmartTRAK's Final 2017 Soft Tissue Fixation Market Financial Results

Posted by Kristina Meyer on 4/16/18 9:44 AM

Pricing pressure and commoditization slows Soft Tissue Fixation Market but 2017 still finishes strong

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 US Soft Tissue Market Recap and Financial Dashboard.

Among the many topics covered in the Q417/FY17 Soft Tissue Fixation Market Recap are:

Read More

Topics: Orthopedics-Soft Tissue Fixation

Ziptek's Resorbable Suture Button for Soft Tissue Repair

Posted by Kristina Meyer on 2/2/18 9:00 AM

Taking on the orthopedic soft-tissue repair market with a novel, zip-tie inspired platform for knotless tissue repair and attachment

With the zip tie as inspiration, Sarasota, FL-based start-up Ziptek, LLC hopes to revolutionize the soft-tissue repair industry with a novel, self-locking, resorbable suture button for soft-tissue repair designed to facilitate natural tissue regeneration, strengthen the repair, and provide an alternative to knotless anchor devices in the US market for orthopedic soft tissue fixation, which is projected to reach over $1.8B by 2021E. 

Read More

Topics: Orthopedics-Soft Tissue Fixation

Catalyst OrthoScience Rethinks Total Shoulder Arthroplasty

Posted by Kristina Meyer on 12/21/17 5:48 PM

Catalyst OrthoScience speaks with SmartTRAK at the Orthopedic Summit Meeting (OSET) 2017 regarding the Company’s next generation total shoulder solution and its strategy for competing with the big players in this space

The Catalyst CSR Total Shoulder System is the result of the visionary insight of Steven Goldberg, MD, a fellowship-trained orthopedic surgeon and shoulder specialist, who devised the next generation, higher precision, less-invasive total shoulder solution with a greatly simplified method of implant placement. In 2011, Dr. Goldberg began development of the revolutionary implant with the new shape and created prototypes using a 3D printing service. Armed with two U.S. provisional patents and positive feedback from several prominent shoulder specialists, the Catalyst CSR Total Shoulder System was born.

Click on the video below to view SmartTRAK’s interview with Dr. Steven Goldberg, Founder & CMO, of Catalyst OrthoScience recorded live at the OSET meeting 2017.  (04:02 minutes)

 

Read More

Topics: Orthopedics-Total Joints

SmartTRAK Publication Alert: Q317 Orthopedics Soft Tissue Fixation Quarterly Market Recap

Posted by Kristina Meyer on 12/19/17 2:24 PM

Q317 Soft Tissue Fixation Market: Flat Growth vs Q217

The Soft Tissue Fixation Market saw flat QoQ growth in Q317, as a mix of supply chain issues, increasing competition, specialized sales forces and seasonality caused the major players to take one step forward and one step backward during the quarter.

By Kristina Meyer, Sr Analyst, Sports Medicine

Although soft tissue fixation growth in the US was up YoY, growth was nearly flat as compared with Q217. In a specialty where many surgeries are elective, seasonality plays a part. Case volumes often dip during summer months as both surgeons and patients take vacations. In contrast, case volumes typically rebound heavily in Q4 as deductibles renew the first of each year. Most of the major players in the soft tissue fixation market, including  Arthrex Smith & Nephew  (SNN),  Zimmer Biomet  (ZBH) and CONMED Linvatec (CNMD) took one step forward in Q317 and one step back. 

Read More

Topics: Orthopedics-Soft Tissue Fixation

Trice Medical: Revolutionizing Orthopedic Diagnostics

Posted by Kristina Meyer on 12/17/17 10:01 PM

At the 2017 Orthopedic Summit (OSET) meeting in Las Vegas, Mark Foster, Trice Medical’s Chief Commercialization Officer and VP of Worldwide Sales, spoke with SmartTRAK's Kristina Meyer about the Company’s revolutionary new technology that is improving the way orthopedic injuries are diagnosed. Trice Medical’s newest product, mi-eye 2, is a fully disposable, integrated camera (the size of a 14-gauge needle) with plug-and-play technology that is FDA cleared to provide illumination and visualization during diagnostic and operative arthroscopic and endoscopic procedures. These procedures can be performed in the clinic setting and provide patients with immediate and definitive diagnoses while significantly reducing the overall cost to the healthcare system.

A transcript of SmartTRAK’s interview with Trice Medical is below, as is the video interview, recorded live at the 2017 OSET meeting: (11:27 min.) 

Read More

Topics: Orthopedics-Trauma

One Stop Shop Strategy Drives Orthopedic 2017 Product Trends

Posted by Kristina Meyer on 10/31/17 4:03 PM

SmartTRAK Analysis Article

In 2017 companies are showcasing new initiatives and products designed to round out their portfolios and help them gain market share by becoming a one stop shop for providers. Read three big trends from SmartTRAK. 

Read More

Topics: Orthopedic

SmartTRAK’s Top Trends in Sports Medicine

Posted by Kristina Meyer on 9/4/15 3:51 PM

 By Kristina Meyer, Sr Analyst, Sports Medicine; Harriet Schwartzman, Sr Analyst, OrthoBiologics, title
Sept. 4, 2015

Tuck in acquisitions, regenerative medicine and soft tissue fixation major themes going forward

Trend #1: Consolidation on a Large Scale Done, Mostly Tuck-In Acquisitions Going Forward

Now that the Zimmer Biomet merger is a done deal, the number of major players in the arthroscopy/sports medicine market has dwindled to a mere five. Consolidation has already hit this market with Smith & Nephew’s (S&N) $1.6B acquisition of Arthrocare in 2014 and CONMED’s partnership with MTF’s Sports Medicine subsidiary in 2012. Interestingly enough, Medtronic inherited a line of soft tissue fixation devices from their recent purchase of Covidien, however, it is not certain what the Company will do, if anything, with these products. As a result of these recent take-outs, exhibitors on the floor of the American Association of Sports Medicine (AOSSM) meeting in Orlando in July were noticeably fewer with the usual suspects, Arthrex, S&N, Zimmer Biomet, and Stryker, only getting larger. M&A going forward will likely result in smaller deals such as Stryker’s 2013 acquisition of hip arthroscopy developer, Pivot Medical, as companies look to fill gaps in their product portfolio.

Read More

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts